{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:30:50Z","timestamp":1793050250587,"version":"4.5.0"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1097\/fpc.0b013e328329940b","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T22:49:50Z","timestamp":1242946190000},"page":"353-362","source":"Crossref","is-referenced-by-count":91,"title":["Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 \u221224C>T polymorphism in young and adult patients with epilepsy"],"prefix":"10.1097","volume":"19","author":[{"given":"Mike","family":"Ufer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Mosyagin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiltrud","family":"Muhle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thies","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sierk","family":"Haenisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"H\u00e4sler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Faltraco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Remmler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"von Spiczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heyo K.","family":"Kroemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Runge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Boor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Stephani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingolf","family":"Cascorbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210212","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.315.7113.924","article-title":"Epilepsy in childhood","volume":"315","author":"Neville","year":"1997","journal-title":"BMJ"},{"key":"R2-5-20210212","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N Engl J Med"},{"key":"R3-5-20210212","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/brain\/awh682","article-title":"Molecular and cellular mechanisms of pharmacoresistance in epilepsy","volume":"129","author":"Remy","year":"2006","journal-title":"Brain"},{"key":"R4-5-20210212","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1528-1167.2005.54904.x","article-title":"Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms","volume":"46","author":"Schmidt","year":"2005","journal-title":"Epilepsia"},{"key":"R5-5-20210212","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00019052-200304000-00013","article-title":"Mechanisms of antiepileptic drug resistance","volume":"16","author":"Sisodiya","year":"2003","journal-title":"Curr Opin Neurol"},{"key":"R6-5-20210212","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1528-1157.2003.42802.x","article-title":"Widespread upregulation of drug-resistance proteins in fatal human status epilepticus","volume":"44","author":"Sisodiya","year":"2003","journal-title":"Epilepsia"},{"key":"R7-5-20210212","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.clpt.2004.04.011","article-title":"Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans","volume":"76","author":"Giessmann","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"R8-5-20210212","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1517\/14656566.6.8.1305","article-title":"The role of common variation in drug transporter genes in refractory epilepsy","volume":"6","author":"Soranzo","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"R9-5-20210212","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1101\/gr.1965304","article-title":"Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene","volume":"14","author":"Soranzo","year":"2004","journal-title":"Genome Res"},{"key":"R10-5-20210212","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1056\/NEJMoa021986","article-title":"Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1","volume":"348","author":"Siddiqui","year":"2003","journal-title":"N Engl J Med"},{"key":"R11-5-20210212","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1212\/01.WNL.0000141021.42763.F6","article-title":"Association of an ABCB1 gene haplotype with pharmacoresistance in temporal lobe epilepsy","volume":"63","author":"Zimprich","year":"2004","journal-title":"Neurology"},{"key":"R12-5-20210212","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.pharmthera.2006.04.009","article-title":"Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs","volume":"112","author":"Cascorbi","year":"2006","journal-title":"Pharmacol Ther"},{"key":"R13-5-20210212","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1126\/science.1135308","article-title":"A silent polymorphism in the MDR1 gene changes substrate specificity","volume":"315","author":"Kimchi-Sarfaty","year":"2007","journal-title":"Science"},{"key":"R14-5-20210212","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/FPC.0b013e3282f85e36","article-title":"Functional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugs","volume":"18","author":"Hung","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"R15-5-20210212","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.seizure.2006.02.015","article-title":"Lack of association between C3435T nucleotide MDR1 genetic polymorphism and multidrug-resistant epilepsy","volume":"15","author":"Kim","year":"2006","journal-title":"Seizure"},{"key":"R16-5-20210212","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1528-1167.2006.00444_1.x","article-title":"Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment","volume":"47","author":"Basic","year":"2006","journal-title":"Epilepsia"},{"key":"R17-5-20210212","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1528-1167.2005.46304.x","article-title":"Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment","volume":"46","author":"Sills","year":"2005","journal-title":"Epilepsia"},{"key":"R18-5-20210212","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1212\/01.WNL.0000137051.33486.C7","article-title":"Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy","volume":"63","author":"Tan","year":"2004","journal-title":"Neurology"},{"key":"R19-5-20210212","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2217\/14622416.7.4.551","article-title":"ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients","volume":"7","author":"Seo","year":"2006","journal-title":"Pharmacogenomics"},{"key":"R20-5-20210212","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1111\/j.1528-1167.2008.01661.x","article-title":"Association of ABCB1 genetic variants 3435C>T and 2677G>T to ABCB1 mRNA and protein expression in brain tissue from refractory epilepsy patients","volume":"49","author":"Mosyagin","year":"2008","journal-title":"Epilepsia"},{"key":"R21-5-20210212","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1124\/jpet.103.049858","article-title":"Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity","volume":"306","author":"Potschka","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"R22-5-20210212","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/FPC.0b013e3282f974b7","article-title":"Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinolol","volume":"18","author":"Haenisch","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"R23-5-20210212","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.tpj.6500403","article-title":"Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex","volume":"7","author":"Haenisch","year":"2007","journal-title":"Pharmacogenomics J"},{"key":"R24-5-20210212","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.clpt.2006.08.012","article-title":"High-dose methotrexate in pediatric acute lymphoblastic leukemia: impact of ABCC2 polymorphisms on plasma concentrations","volume":"80","author":"Rau","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"R25-5-20210212","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/01.tp.0000235533.29300.e7","article-title":"Multidrug resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients","volume":"82","author":"Naesens","year":"2006","journal-title":"Transplantation"},{"key":"R26-5-20210212","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/01.fpc.0000236337.41799.b3","article-title":"MRP2 haplotypes confer differential susceptibility to toxic liver injury","volume":"17","author":"Choi","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"R27-5-20210212","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1053\/j.gastro.2006.11.023","article-title":"Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes","volume":"132","author":"Daly","year":"2007","journal-title":"Gastroenterology"},{"key":"R28-5-20210212","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1365-2710.1999.00201.x","article-title":"Clinically significant pharmacokinetic drug interactions between antiepileptic drugs","volume":"24","author":"Tanaka","year":"1999","journal-title":"J Clin Pharm Ther"},{"key":"R29-5-20210212","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00008571-200106000-00002","article-title":"The effect of genetic polymorphism of cytochrome P450 CYP2C9 on phenytoin dose requirement","volume":"11","author":"Van der Weide","year":"2001","journal-title":"Pharmacogenetics"},{"key":"R30-5-20210212","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00007691-200004000-00016","article-title":"Genetic polymorphism of the CYP2C subfamily and excessive serum phenytoin concentration with central nervous system intoxication","volume":"22","author":"Ninomiya","year":"2000","journal-title":"Ther Drug Monit"},{"key":"R31-5-20210212","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/00008571-200110000-00005","article-title":"Phenytoin metabolic ratio: a putative marker of CYP2C9 activity in vivo","volume":"11","author":"Caraco","year":"2001","journal-title":"Pharmacogenetics"},{"key":"R32-5-20210212","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJM199601183340308","article-title":"Antiepileptic drugs","volume":"334","author":"Brodie","year":"1996","journal-title":"N Engl J Med"},{"key":"R33-5-20210212","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","article-title":"Proposal for revised clinical and electroencephalographic classification of epileptic seizures","volume":"22","year":"1981","journal-title":"Epilepsia"},{"key":"R34-5-20210212","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Proposal for revised clinical and electroencephalographic classification of epilepsies and epileptic syndromes","volume":"30","year":"1989","journal-title":"Epilepsia"},{"key":"R35-5-20210212","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Statist Soc B"},{"key":"R36-5-20210212","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2174\/1567201043334650","article-title":"Relevance of multidrug resistance proteins on the clinical efficacy of cancer therapy","volume":"1","author":"Merino","year":"2004","journal-title":"Curr Drug Deliv"},{"issue":"1","key":"R37-5-20210212","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1528-1167.2007.00993.x","article-title":"Drug transporters in the epileptic brain","volume":"48","author":"Loscher","year":"2007","journal-title":"Epilepsia"},{"key":"R38-5-20210212","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1073\/pnas.97.7.3473","article-title":"Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo","volume":"97","author":"Hoffmeyer","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R39-5-20210212","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1741-7015-2-37","article-title":"Significance of MDR1 and multiple drug resistance in refractory human epileptic brain","volume":"2","author":"Marchi","year":"2004","journal-title":"BMC Med"},{"key":"R40-5-20210212","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/01.fpc.0000230408.23146.b1","article-title":"Common ABCB1 polymorphisms are not associated with multidrug resistance in epilepsy using a gene-wide tagging approach","volume":"17","author":"Leschziner","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"R41-5-20210212","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.eplepsyres.2006.10.004","article-title":"The controversial association of ABCB1 polymorphisms in refractory epilepsy: an analysis of multiple SNPs in an Irish population","volume":"73","author":"Shahwan","year":"2007","journal-title":"Epilepsy Res"},{"key":"R42-5-20210212","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neuroscience.2004.07.051","article-title":"Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain","volume":"129","author":"Nies","year":"2004","journal-title":"Neuroscience"},{"key":"R43-5-20210212","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1046\/j.1528-1157.2001.12301.x","article-title":"Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy","volume":"42","author":"Dombrowski","year":"2001","journal-title":"Epilepsia"},{"key":"R44-5-20210212","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.eplepsyres.2005.11.011","article-title":"Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis","volume":"68","author":"Kubota","year":"2006","journal-title":"Epilepsy Res"},{"key":"R45-5-20210212","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1602\/neurorx.2.1.86","article-title":"Blood-brain barrier active efflux transporters: ATP-binding cassette gene family","volume":"2","author":"Loscher","year":"2005","journal-title":"NeuroRx"},{"key":"R46-5-20210212","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/jpet.106.102491","article-title":"Valproic acid is not a substrate for P-glycoprotein or multidrug resistance proteins 1 and 2 in a number of in vitro and in vivo transport assays","volume":"320","author":"Baltes","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"R47-5-20210212","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.eplepsyres.2003.12.008","article-title":"Valproic acid uptake by bovine brain microvessel endothelial cells: role of active efflux transport","volume":"58","author":"Gibbs","year":"2004","journal-title":"Epilepsy Res"},{"key":"R48-5-20210212","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuropharm.2006.07.038","article-title":"Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein","volume":"52","author":"Baltes","year":"2007","journal-title":"Neuropharmacology"},{"key":"R49-5-20210212","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1528-1167.2006.00939.x","article-title":"Upregulation of brain expression of P-glycoprotein in MRP2-deficient TR(-) rats resembles seizure-induced up-regulation of this drug efflux transporter in normal rats","volume":"48","author":"Hoffmann","year":"2007","journal-title":"Epilepsia"},{"key":"R50-5-20210212","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1211\/jpp.60.5.0009","article-title":"ABCC2 haplotype is not associated with drug-resistant epilepsy","volume":"60","author":"Seo","year":"2008","journal-title":"J Pharm Pharmacol"},{"key":"R51-5-20210212","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0009-9236(01)95478-5","article-title":"Severe phenytoin intoxication in a subject homozygous for CYP2C9*3","volume":"70","author":"Brandolese","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"R52-5-20210212","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/FTD.0b013e318030def0","article-title":"Population estimation of the effects of cytochrome P450 2C9 and 2C19 polymorphisms on phenobarbital clearance in Japanese","volume":"29","author":"Goto","year":"2007","journal-title":"Ther Drug Monit"},{"key":"R53-5-20210212","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/toxsci\/kfl096","article-title":"Contribution of CYP2C9, CYP2A6, and CYP2B6 to valproic acid metabolism in hepatic microsomes from individuals with the CYP2C9*1\/*1 genotype","volume":"94","author":"Kiang","year":"2006","journal-title":"Toxicol Sci"},{"key":"R54-5-20210212","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2165\/00003088-199631030-00004","article-title":"Clinically significant pharmacokinetic drug interactions with carbamazepine. An update","volume":"31","author":"Spina","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"R55-5-20210212","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1600-0404.2005.00507.x","article-title":"Diagnosing and predicting refractory epilepsy","volume":"181","author":"Brodie","year":"2005","journal-title":"Acta Neurol Scand Suppl"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/01213011-200905000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T16:50:30Z","timestamp":1739119830000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-200905000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0b013e328329940b","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}